ST’s body-wear sensor powers Preventice’ Remote Monitoring System
STMicroelectronics and Preventice have announced that ST is offering wearable body sensor technologies to power the new BodyGuardian Remote Monitoring System (RMS) from Preventice. Preventice recently announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BodyGuardian RMS, permitting Preventice to market and sell BodyGuardian to hospitals and clinics for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients.
“A key goal for ST is to enable our customers to quickly develop solutions that contribute to people enjoying a better quality of life; ST makes that possible through our unique ability to provide the complete breadth of products and technologies required for their applications,” said Benedetto Vigna, Executive Vice President and General Manager Analog, MEMS and Sensors Group, STMicroelectronics. “The clearance from the FDA of the Preventice BodyGuardian System clearly demonstrates our expertise in helping customers develop medical-grade electronics for demanding markets.”
The BodyGuardian RMS utilizes clinical algorithms which were developed by doctors at Mayo Clinic to help remote monitoring of individuals with cardiac arrhythmias. The BodyGuardian System is to permit physicians to monitor key biometrics outside of the clinical setting, while patients go about their daily lives, by allowing a continuous connection between the patient and their physicians.
According to Preventice, this connection is made possible by a small body-worn sensor that is attached to the patient’s chest. This sensor collects important data such as the patient’s ECG, heart rate, respiration rate, and activity level and transmits that data to physicians via mobile-phone technology, allowing doctors to monitor patients from their iPad or desktop. The wearable body sensor in the BodyGuardian RMS is enabled by ST hardware and software technology that consists of sophisticated MEMS, low-power STM32 microcontrollers, and analog components combined with advanced ST-proprietary algorithms.
“ST is a pioneer and leader in the sensor industry and working with them allows us to bring the high-end, clinical monitoring technology developed by Mayo Clinic and Preventice to a broader base of patients,” said Jon Otterstatter, co-founder, president and CEO of Preventice. “Our goal at Preventice is to bring sophisticated remote patient monitoring to patients where they live, work and play—creating an environment of continuous care for patients with cardiac arrhythmias and a variety of other chronic conditions.”
The potential for remote patient monitoring to decrease patient costs and persuade care delivery is contributing to fast growth in the use of wireless monitoring, which is likely to continue in the coming years. In fact, recent research from Kalorama shows that the U.S. market for advanced patient monitoring systems has grown from $3.9 billion in 2007, to $8.9 billion in 2011. The market is predicted to reach $20.9 billion by 2016, according to this same study.
Source: ST Microelectronics